Results 211 to 220 of about 181,298 (332)
Pulsed field ablation as a bailout for ventricular tachycardia ablation: a case report. [PDF]
Verhaeghe L +4 more
europepmc +1 more source
In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj +6 more
wiley +1 more source
Lidocaine and remifentanil for ventricular tachycardia suppression in a dog: A case report. [PDF]
Pahim ABS +8 more
europepmc +1 more source
Iatrogenic ‘torsade de pointes’ ventricular tachycardia
Nicholas G. Kounis
openalex +1 more source
Antimicrobial prescribing guidelines for horses in Australia
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt +18 more
wiley +1 more source
Role of Intracardiac Echocardiography in Ventricular Tachycardia Ablation: Where Is the Scar? [PDF]
Heller T +3 more
europepmc +1 more source
Recurrent sustained ventricular tachycardia. 2. Endocardial mapping.
Mark E. Josephson +5 more
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Monomorphic Ventricular Tachycardia. [PDF]
Hussain F +9 more
europepmc +1 more source
Cardiovascular Health in Women—Across the Lifespan
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar +5 more
wiley +1 more source

